ROP
53
-9
JWN
48
-2
VRTX
47
-6
IRM
41
3
AMGN
42
-4
MAS
52
-4
DFS
64
2
GE
61
-3
LEN
50
-2
CMA
61
-3
K
51
-3
OMC
50
-16
PCAR
56
-5
CAH
48
-6
DNB
74
-6
DRI
50
-3
NSC
53
-4
ZTS
47
2
NWSA
62
-7
MSFT
46
-11
ROP
53
-9
JWN
48
-2
VRTX
47
-6
IRM
41
3
AMGN
42
-4
MAS
52
-4
DFS
64
2
GE
61
-3
LEN
50
-2
CMA
61
-3
K
51
-3
OMC
50
-16
PCAR
56
-5
CAH
48
-6
DNB
74
-6
DRI
50
-3
NSC
53
-4
ZTS
47
2
NWSA
62
-7
MSFT
46
-11
Financhill
Back

Ellsworth Growth and Income Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
56

ECF
Ellsworth Growth and Income Fund

Last Price:
9.47
Seasonality Move:
3.92%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
56
Ellsworth Growth and Income Fund (ECF) is a Buy

Is Ellsworth Growth and Income Fund a Buy, Sell or Hold?

  • The current Ellsworth Growth and Income Fund [ECF] share price is $9.47. The Score for ECF is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • ECF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ECF Stock Price Chart

What is Ellsworth Growth and Income Fund's stock price today?

  • The Ellsworth Growth and Income Fund share price today is $9.47
    The current trend is moderately bullish and ECF is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ECF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 56.17 Buy
Chaikin Money Flow: 19755 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.2 - 9.52) Buy
Bollinger Bands (100): (8.4 - 9.22) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

ECF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.58 Sell
20-day SMA: 9.39 Buy
50-day SMA: 9.15 Buy
200-day SMA: 8.41 Buy
8-day EMA: 9.52 Sell
20-day EMA: 9.41 Buy
50-day EMA: 9.18 Buy
200-day EMA: 8.61 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Ellsworth Growth and Income Fund Earnings Growth & ECF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Ellsworth Growth and Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):